Elevated PTX3 levels are associated with higher CKD patient mortality,increased CKD and CVD risk [19], [20], [51].Endothelial dysfunction, often linked to heightenedPTX 3 levels, is hypothesized to contribute to the augmentedCVD risk in CKD [52]. The gene discussed is PTX3; the disease is endothelial dysfunction.